The facility of Vayam Research Solutions Limited in Gandhinagar Gujarat is completed and having received DCGI approval for a period of 5 years, has been poo for commencing its operations.
Vayam has started the first Pilot study from Emcure Pharmaceuticals, India. This Bio Equivalence is for a product intended to be submitted to the EU regulator (EMA) to be carried out in India and is a major milestone in the longterm association with Emcure Pharmaceuticals. The promoters of the Company are not interested/related to the said order received.
*Vanta Clinical Research Limited ("VCRL") is a wholly owned subsidiary of Vanta Bioscience Limited and VCRL holds 36% in Vayam.